Section Arrow
Quote
CNSP.NASDAQ
- CNS Pharmaceuticals Inc
Quotes are at least 15-min delayed:2026/05/26 05:42 EDT
Pre Market
Last
 5.5318
+0.1118 (+2.06%)
Bid
5.45
Ask
6.48
High 5.845 
Low 5.2636 
Volume 168 
Regular Hours (Closed)
Last
 5.42
+0.37 (+7.33%)
Day High 
5.42 
Prev. Close
5.05 
1-M High
10.54 
Volume 
23.87K 
Bid
5.45
Ask
6.48
Day Low
5.07 
Open
5.07 
1-M Low
1.9 
Market Cap 
7.38M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.53 
20-SMA 4.9 
50-SMA 3.42 
52-W High 13.7988 
52-W Low 1.9 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-24.12/-1.68
Enterprise Value
7.38M
Balance Sheet
Book Value Per Share
0.05
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
GOVXGeoVax Labs Inc.3.64+0.89+32.36%-- 
Pre Market 3.81 +0.17 +4.67%
MTVAMetaVia Inc.3.85+0.98+34.15%-- 
Pre Market 3.4305 -0.4195 -10.90%
AKTXAkari Therapeutics Plc18.27+13.13+255.45%-- 
Pre Market 13.96 -4.31 -23.59%
LIMNLiminatus Pharma Inc0.1694-0.0766-31.14%-- 
Pre Market 0.16 -0.0094 -5.55%
IOVAIovance Biotherapeutics4.11+0.41+11.08%-- 
Pre Market 4.07 -0.04 -0.97%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.